Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Dr. Richard Law, a former Exscientia executive who helped build the company and facilitate its merger with Recursion ...
Top holdings in the Vanguard Consumer Staples ETF ( VDC 1.09%) include retailers like Costco Wholesale and Walmart, every-day ...
The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Deaconess Health System announced Tuesday morning that former Indiana Lt. Gov. Suzanne Crouch has been named system executive director of the Deaconess Foundation effective March 2025.
With former Eli Lilly and Company CEO John Lechleiter, Crouch founded the Indiana Roundtable on Mental Health, a partnership with the Indianapolis Colts, Indiana Pacers, the Indiana Chamber, Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback